Vir Biotechnology, Inc. · NASDAQ:VIR
Sabatini Brent sold 379 Vir Biotechnology, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 2, 2026
On Jun 1, 2026, Sabatini Brent (SVP, Chief Accounting Officer) sold 379 Vir Biotechnology, Inc. shares at US$9.45 for US$3,582 under a trading plan, leaving 61,902 shares. Filed Jun 2, 2026 (Form 4).
- Sold
- 379 shares
- Price
- US$9.45
- Value
- US$3,582
- Holding after
- 61,902 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Sale | 379 | US$9.45 | 61,902 | Direct |
Source
Related
- Vir Biotechnology, Inc.
- Sabatini Brent
- Vir Biotechnology, Inc. shareholders
- Form 4 · More Robert J · Aug 12, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4 · Coughlin Timothy · Jun 10, 2026
- Form 4 · Napolitano Janet · Jun 2, 2026